Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme

Heart Lung Circ. 2024 Nov;33(11):1523-1532. doi: 10.1016/j.hlc.2024.08.008. Epub 2024 Sep 6.

Abstract

Atrial fibrillation (AF) is highly prevalent in the Australian community, ranking amongst the highest globally. The consequences of AF are significant. Stroke, dementia and heart failure risk are increased substantially, hospitalisations are amongst the highest for all cardiovascular causes, and Australians living with AF suffer from substantial symptoms that impact quality of life. Australian research has made a significant impact at the global level in advancing the care of patients living with AF. However, new strategies are required to reduce the growing incidence of AF and its associated healthcare demand. The Australian Cardiovascular Alliance (ACvA) has led the development of an arrhythmia clinical theme with the objective of tackling major research priorities to achieve a reduction in AF burden across Australia. In this summary, we highlight these research priorities with particular focus on the strengths of Australian research and the strategies needed to move forward in reducing incident AF and improving outcomes for those who live with this chronic condition.

Keywords: Atrial fibrillation; Catheter ablation; Electrophysiology; Genetics; Mechanisms; Prevention.

Publication types

  • Review

MeSH terms

  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / therapy
  • Australia / epidemiology
  • Biomedical Research
  • Humans
  • Quality of Life
  • Research